CDKN2A and acute lymphoblastic leukemia: According to earlier research, the T-ALL genome frequently demonstrates CNAs in NOTCH1 and cyclin-dependent kinase inhibitor 2A/2B (CDKN2A/2B) cell cycle regulators.